C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/519 (2006.01) A61P 31/12 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2532049
Disclosed are polymorphs of the isethionate salt of 6-acetyl-8-cyclopentyl-5- methyl-2~(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one, which is a selective cyclin-dependent kinase 4 (CDK4) inhibitor useful for treating inflammation and cell proliferative diseases such as cancer and restenosis.
L'invention concerne des polymorphes du sel d'iséthionate de 6-acétyl-8-cyclopentyl-5-méthyl-2-(5-pipérazin-1-yl-pyridin-2-ylamino)-8<I>H</I>-pyrido[2,3-d]pyrimidin-7-one, qui est un inhibiteur sélectif de la kinase 4 dépendante des cyclines, utile pour traiter l'inflammation et les maladies proliférantes cellulaires comme le cancer et la resténose.
Beylin Vladimir Genukh
Blackburn Anthony Clyde
Erdman David Thomas
Toogood Peter Laurence
Torys Llp
Warner-Lambert Company Llc
LandOfFree
Isethionate salt of a selective cdk4 inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isethionate salt of a selective cdk4 inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isethionate salt of a selective cdk4 inhibitor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1562065